Journal Mobile Options
Table of Contents
Vol. 7, No. 4, 2007
Issue release date: September 2007
Pancreatology 2007;7:325–331

Pancreatic Fistula after Pancreaticoduodenectomy: Diagnosed according to International Study Group Pancreatic Fistula (ISGPF) Definition

Liang T.-B. · Bai X.-L. · Zheng S.-S.
Department of Hepato-Biliary-Pancreatic Surgery, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, PR China

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Aims: The aim of the study is to validate a new classification of pancreatic fistula (PF) and to document risk factors for PF. Methods: A retrospective study was performed on 100 patients who underwent pancreaticoduodenectomy (PD) within a 2-year period. PF was diagnosed according to the criteria developed by an International Study Group on Pancreatic Fistula (ISGPF). Sixteen pre- and intraoperative risk factors for PF were analyzed. Results: Of 100 patients 32 developed PF; grade A in 21 patients, grade B in 10, and grade C in 1.Four risk factors including pathological diagnosis, concomitant surgery, diameter of pancreatic duct, and texture of the remnant pancreas were found to be significantly associated with PF by univariate analysis. Texture of the remnant pancreas and concomitant surgery were demonstrated to be independent risk factors by multivariate logistic regression. If a PF occurred, advanced age was found to be a risk factor for PF grade B by univariate analysis, but age was not an independent risk factor by multivariate logistic regression. Conclusions: The status of the remnant pancreas is identified asa substantial risk factor for PF after PD. When soft remnant pancreas is encountered, more careful handling is required in an attempt to minimize the rate of PF. This study confirms that the ISGPF classification of PF is useful.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA: Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248–260.
  2. Bassi C, Massimo F, Salvia R, Mascetta G, Molinari E, Pederzoli P: Management of complications after pancreticoduodenectomy in a high volume center: results on 150 consecutive patients. Dig Surg 2001;18:453–458.
  3. Tani M, Onishi H, Kinoshita H, Kawai M, Ueno M, Hama T, Uchivama K, Yamaue H: The evaluation of duct-to-mucosa pancreaticojejunostomy in pancreaticoduodenectomy. World J Surg 2005;29:76–79.
  4. Gouma DJ, van Geenen RC, van Gulik TM, de Hanan RJ, de Wit LT, Busch OR, Obertop H: Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 2000;232:786–795.
  5. Büchler MW, Friess H, Wagner M, Kulli C, Wagener V, Z’graggen K: Pancreatic fistula after pancreatic head resection. Br J Surg 2000;87:883–889.
  6. Marcus SG, Cohen H, Ranson JH: Optimal management of the pancreatic remnant after pancreticoduodenectomy. Ann Surg 1995;221:635–648.
  7. Suc B, Msika S, Fingerhut A, Fourtanier G, Hay JM, Holmieres F, Sastre B, Fagniez PL, the French Associations for Surgical Research: Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection. Ann Surg 2003;237:57–65.
  8. Khan AW, Agarwal AK, Davidson BR: Isolated Roux loop duct-to-mucosa pancreaticojejunostomy avoids pancreatic leaks in pancreticoduodenectomy. Dig Surg 2002;19:199–204.
  9. Batignani G, Fratini G, Zuckermann M, Bianchini E, Tonelli F: Comparison of Wirsung-jejunal duct-to-mucosa and dunking technique for pancreatojejunostomy after pancretoduodenectomy. Hepatobiliary Pancreat Dis Int 2005;4:450–455.

    External Resources

  10. Ohwada S, Tanahashi Y, Ogawa T, Kawate S, Hamada K, Tago K, Yamada T, Morishita Y: In situ versus ex situ pancreatic duct stents of duct-to-mucosa pancreaticojejunostomy after pancreticoduodenectomy with Billroth I-type reconstruction. Arch Surg 2002;137:1289–1293.
  11. Asopa HS, Garg M, Singhal GG, Singh L, Asopa J: Pancreaticojejunostomy with invagination of spatulated pancreatic stump into a jejunal pouch. Am J Surg 2002;183:138–141.
  12. Okamoto A, Tsuruta K: Fistulation method: simple and safe pancreaticojejunostomy after pancreticoduodenectomy. Surgery 2000;127:433–438.
  13. Tsuji M, Kimura H, Konishi K, Yabushita K, Kiichi M, Kuroda Y: Management of continuous anastomosis of pancreatic duct and jejunal mucosa after pancreticoduodenectomy. Surgery 1998;123:617–621.
  14. Lin JW, Eng M, Cameron JL, Yeo CJ, Riall TS, Lillemoe KD: Risk factors and outcomes in post pancreticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg 2004;8:951–959.
  15. Bassi C, Derveins C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Büchler M, International Study Group on Pancreatic Fistula Definition: Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138:8–13.
  16. Ueno T, Yamamoto K, Kawaoka T, Takashima M, Oka M: Current antibiotic prophylaxis in pancreatoduodenectomy in Japan. J Hepatobiliary Pancreat Surg 2005;12:304–309.
  17. Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, Campbell KA, Choti MA: Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreticoduodenectomy? Ann Surg 2000;232:419–429.
  18. Hosotani R, Doi R, Imamura M: Duct-to-mucosa pancreaticojejunostomy reduces the risk of pancreatic leakage after pancreatoduodenectomy. World J Surg 2002;26:99–104.
  19. Ohwada S, Ogama T, Kawate S, Tanahashi Y, Iwazaki S, Tomizawa N, Yamada T, Ohya T, Morishita Y: Results of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy Billroth 1 type reconstruction in 100 consecutive patients. J Am Coll Surg 2001;193:29–35.
  20. Matsusue S, Takeda H, Nakamura Y, Nishimura S, Koizumi S: A prospective analysis of the factors influencing pancreaticojejunostomy performed using a single method, in 100 consecutive pancreaticoduodenectomy. Surg Today 1998;28:719–726.
  21. Yeh TS, Jan YY, Jeng LB, Hwang TL, Wang CS, Chen SC, Chao TC, Chen MF: Pancreaticojejunal anastomotic leak after pancreaticoduodenectomy-multivariate analysis of perioperative risk factors. J Surg Res 1997;67:119–125.
  22. Van Berge Henegouwen MI, De Wit LT, Van Gulik TM, Obertop H, Gouma DJ: Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg 1997;185:18–25.
  23. Yang YM, Tian XD, Zhuang Y, Wang WM, Wan YL, Huang YT: Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol 2005;11:2456–2461.

    External Resources

  24. Poon R, Lo SH, Fong D, Fan ST, Wong J: Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy. Am J Surg 2002;183:42–52.
  25. Suzuki Y, Fujino Y, Tanioka Y, Hiraoka K, Takada M, Ajiki T, Takavama Y, Ku Y, Kuroda Y: Selection of pancreaticojejunostomy techniques according to pancreatic texture and duct size. Arch Surg 2002;137:1044–1047.
  26. Hesse UJ, DeDecker C, Houtmeyers P, Demetter P, Ceelen W, Pattyn P, Troisi R, de Hemptinne B: Prospectively randomized trial using perioperative low-dose Octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy. World J Surg 2005;29:1325–1328.
  27. Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, Jinnah R, Evans DB: Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 1997;226:632–641.
  28. Z’graggen K, Uhl W, Friess H, Büchler MW: How to do a safe pancreatic anastomosis. J Hepatobiliary Pancreat Surg 2002;9:733–737.
  29. Langrehr JM, Bahra M, Jacob D, Glanemann M, Neuhaus P: Prospective randomized comparison between a new mattress technique and Cattell (duct-to-mucosa) pancreaticojejunostomy for pancreatic resection. World J Surg 2005;29:1111–1119.
  30. Bassi C, Falconi M, Molinari E, Mantovani W, Butturini G, Gumbs AA, Salvia R, Pederzoli P: Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: results of a prospective randomized trial. Surgery 2003;134:766–771.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50